Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
24343 | 264 | 24.5 | 50% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2197 | 4428 | VARICOSE VEINS//PHLEBOLOGY//ENDOVENOUS LASER ABLATION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CALCIUM DOBESILATE | Author keyword | 65 | 75% | 17% | 46 |
2 | ETHAMSYLATE | Author keyword | 19 | 61% | 8% | 20 |
3 | DOBESILATE | Author keyword | 13 | 71% | 4% | 10 |
4 | ETAMSYLATE | Author keyword | 7 | 67% | 2% | 6 |
5 | SERV HISTOL | Address | 2 | 13% | 5% | 13 |
6 | BONE MINERAL DENS MEASUREMENT | Address | 1 | 100% | 1% | 2 |
7 | CIRCULATORY LOAD | Author keyword | 1 | 50% | 1% | 2 |
8 | VEGF VASCULAR ENDOTHELIAL CELL GROWTH FACTOR | Author keyword | 1 | 100% | 1% | 2 |
9 | BRIMONIDINE TARTRATE | Author keyword | 1 | 27% | 2% | 4 |
10 | 2 METHYLHYDROQUINONE | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CALCIUM DOBESILATE | 65 | 75% | 17% | 46 | Search CALCIUM+DOBESILATE | Search CALCIUM+DOBESILATE |
2 | ETHAMSYLATE | 19 | 61% | 8% | 20 | Search ETHAMSYLATE | Search ETHAMSYLATE |
3 | DOBESILATE | 13 | 71% | 4% | 10 | Search DOBESILATE | Search DOBESILATE |
4 | ETAMSYLATE | 7 | 67% | 2% | 6 | Search ETAMSYLATE | Search ETAMSYLATE |
5 | CIRCULATORY LOAD | 1 | 50% | 1% | 2 | Search CIRCULATORY+LOAD | Search CIRCULATORY+LOAD |
6 | VEGF VASCULAR ENDOTHELIAL CELL GROWTH FACTOR | 1 | 100% | 1% | 2 | Search VEGF+VASCULAR+ENDOTHELIAL+CELL+GROWTH+FACTOR | Search VEGF+VASCULAR+ENDOTHELIAL+CELL+GROWTH+FACTOR |
7 | BRIMONIDINE TARTRATE | 1 | 27% | 2% | 4 | Search BRIMONIDINE+TARTRATE | Search BRIMONIDINE+TARTRATE |
8 | 2 METHYLHYDROQUINONE | 1 | 50% | 0% | 1 | Search 2+METHYLHYDROQUINONE | Search 2+METHYLHYDROQUINONE |
9 | ANTI ANGIOGENIC TUMOR THERAPY | 1 | 50% | 0% | 1 | Search ANTI+ANGIOGENIC+TUMOR+THERAPY | Search ANTI+ANGIOGENIC+TUMOR+THERAPY |
10 | CARBOHYDRATE LIPID METABOLISM | 1 | 50% | 0% | 1 | Search CARBOHYDRATE+LIPID+METABOLISM | Search CARBOHYDRATE+LIPID+METABOLISM |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DOXIUM | 26 | 100% | 4% | 11 |
2 | ETHAMSYLATE | 7 | 56% | 3% | 9 |
3 | DOXIUM CALCIUM DOBESILATE | 6 | 80% | 2% | 4 |
4 | BLOOD HYPERVISCOSITY | 5 | 63% | 2% | 5 |
5 | CALCIUM DOBESILATE | 5 | 30% | 5% | 13 |
6 | ETAMSYLATE | 4 | 75% | 1% | 3 |
7 | 1 3 6 NAPHTHALENETRISULFONATE | 2 | 67% | 1% | 2 |
8 | CLS 2210 | 1 | 100% | 1% | 2 |
9 | DOBESILATE | 1 | 50% | 1% | 2 |
10 | CHEMILUMINESCENCE REACTION | 1 | 25% | 2% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids | 2004 | 20 | 53 | 57% |
Calcium dobesilate: Pharmacology and future approaches | 1998 | 27 | 16 | 63% |
Study on the history of Traditional Chinese Medicine to treat diabetes | 2010 | 5 | 9 | 22% |
EFFECT OF CALCIUM DOBESILATE ON BLOOD-VISCOSITY IN DIABETIC MICROANGIOPATHY - A REVIEW | 1986 | 13 | 9 | 56% |
SORPTION METHODS IN THE MULTIPLE MODALITY THERAPY OF CARDIOGENIC-SHOCK | 1984 | 0 | 2 | 100% |
Renoprotective effects of tea catechin in streptozotocin-induced diabetic rats | 2006 | 13 | 15 | 7% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SERV HISTOL | 2 | 13% | 4.9% | 13 |
2 | BONE MINERAL DENS MEASUREMENT | 1 | 100% | 0.8% | 2 |
3 | ARZNEIMITTELFOR | 1 | 50% | 0.4% | 1 |
4 | EQUIPE ACCUEIL EA2381 | 1 | 50% | 0.4% | 1 |
5 | INVEST BIOMED RED DIABET ENFERMEDAD METAB A | 1 | 50% | 0.4% | 1 |
6 | IST CLIN CARDIOVASC | 1 | 50% | 0.4% | 1 |
7 | LPTIM | 1 | 50% | 0.4% | 1 |
8 | PEOPLES HOSP AFFILATED 3 | 1 | 50% | 0.4% | 1 |
9 | PROGRAMA EFECTIVIDAD CLIN | 1 | 50% | 0.4% | 1 |
10 | SERV NEUROCIRUGIA INFANTIL | 1 | 50% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000197420 | HYDROXYETHYLRUTOSIDES//TROXERUTIN//O BETA HYDROXYETHYL RUTOSIDES |
2 | 0.0000114035 | THORACIC DUCT DRAINAGE//CD4 SUPPRESSOR T CELL//GUSPERIMUS HYDROCHLORIDE |
3 | 0.0000106341 | GAULTHERIA YUNNANENSIS//METHYL SALICYLATE 2 O BETA D LACTOSIDE//GAULTHERIN |
4 | 0.0000070367 | ACROSOMAL ENZYME//DEXAMETHSONE//SPERM CHARACTERISTIC |
5 | 0.0000068874 | AGRANULOCYTOSIS//DRUG INDUCED AGRANULOCYTOSIS//EVALUATION SCORE |
6 | 0.0000061058 | BETA TYPE CHELATES//ANTICATARACTOGENIC//ENVIRONM PROTECT POLLUT REMEDIAT WATE |
7 | 0.0000051154 | LYMPH PUMP//CARDIOVASC LYMPHAT BIOL//LYMPHATIC SMOOTH MUSCLE |
8 | 0.0000043107 | CEPES ESTUDOS PESQUISA PREVENCAO TRATAMENTO//NEW SOLUTION OF SIMULTANEOUS EQUATIONS//SIGNAL MULTIPLIER SPECTROPHOTOMETRY |
9 | 0.0000041737 | SOLCOSERYLR//WOUND HEALING DRUGS//ACTOVEGIN |
10 | 0.0000041278 | TOPO OPTICAL STAINING REACTION//PLECKSTRIN HOMOLOGY DOMAIN CONTAINING//ROMHANYI |